REGLUTIDE 1.34mg/ml sc Injection contains Liraglutide 1.34 mg/ml. It is a glucagon-like peptide-1 (GLP-1) receptor agonist medicine used to improve blood sugar control in patients with type 2 diabetes mellitus and to support weight management in appropriate patients.
Uses:
Treatment of type 2 diabetes mellitus along with diet and exercise.
Improvement of blood glucose control.
Reduction of the risk of cardiovascular events in certain adults with type 2 diabetes and cardiovascular disease.
Weight management in patients with obesity or overweight conditions as prescribed.
Dose:
Adults: Usually started with 0.6 mg once daily by subcutaneous injection, then increased gradually according to the physician's advice.
Inject under the skin of the abdomen, thigh, or upper arm as directed.
Use the medicine exactly as prescribed by a healthcare professional.
Dose and duration depend on the patient's condition and response to treatment.